196 related articles for article (PubMed ID: 25855331)
1. FDA approves Gardasil 9 for more types of HPV.
Printz C
Cancer; 2015 Apr; 121(8):1156-7. PubMed ID: 25855331
[No Abstract] [Full Text] [Related]
2. FDA approves new upgraded Gardasil 9.
Kirby T
Lancet Oncol; 2015 Feb; 16(2):e56. PubMed ID: 25532625
[No Abstract] [Full Text] [Related]
3. Committee Opinion Summary No. 641: Human Papillomavirus Vaccination.
Obstet Gynecol; 2015 Sep; 126(3):693. PubMed ID: 26287785
[TBL] [Abstract][Full Text] [Related]
4. The potential of human papillomavirus vaccines.
Steinbrook R
N Engl J Med; 2006 Mar; 354(11):1109-12. PubMed ID: 16540608
[No Abstract] [Full Text] [Related]
5. FDA approves quadrivalent HPV vaccine for use in males ages 9-26 years.
Garg A; Guez G
Dent Implantol Update; 2011 Mar; 22(3):23-4. PubMed ID: 21425752
[No Abstract] [Full Text] [Related]
6. Concerned about HPV-related cancer rise, researchers advocate boosting HPV vaccination rates.
Azvolinsky A
J Natl Cancer Inst; 2013 Sep; 105(18):1335-6. PubMed ID: 23990671
[No Abstract] [Full Text] [Related]
7. Gardasil 9--a broader HPV vaccine.
Med Lett Drugs Ther; 2015 Mar; 57(1465):47-8. PubMed ID: 25853579
[No Abstract] [Full Text] [Related]
8. Gardasil: Introducing the new human papillomavirus vaccine.
McLemore MR
Clin J Oncol Nurs; 2006 Oct; 10(5):559-60. PubMed ID: 17063609
[TBL] [Abstract][Full Text] [Related]
9. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):626-9. PubMed ID: 20508593
[TBL] [Abstract][Full Text] [Related]
10. Immunizing against Anogenital Cancer: HPV Vaccines.
Pogoda CS; Roden RB; Garcea RL
PLoS Pathog; 2016 May; 12(5):e1005587. PubMed ID: 27196109
[No Abstract] [Full Text] [Related]
11. Protecting children from HPV: challenges and opportunities.
Rollins JA
Pediatr Nurs; 2011; 37(6):292-3, 301. PubMed ID: 22256689
[No Abstract] [Full Text] [Related]
12. FDA licensure of quadrivalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP).
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2010 May; 59(20):630-2. PubMed ID: 20508594
[TBL] [Abstract][Full Text] [Related]
13. The HPV vaccine controversy.
Intlekofer KA; Cunningham MJ; Caplan AL
Virtual Mentor; 2012 Jan; 14(1):39-49. PubMed ID: 23116916
[No Abstract] [Full Text] [Related]
14. HPV protection in older groups may be in the eye of the beholder.
Jones N
Nat Med; 2011 Jun; 17(6):637. PubMed ID: 21647126
[No Abstract] [Full Text] [Related]
15. Who should get the HPV vaccine? Usage expands amid debate.
Peres J
J Natl Cancer Inst; 2010 Jun; 102(12):838-40. PubMed ID: 20530765
[No Abstract] [Full Text] [Related]
16. Human papillomavirus vaccine: an updated position statement of the Society for Adolescent Health and Medicine.
Friedman L; Bell DL; Kahn JA; Marcell AV; Middleman AB; Rosenthal SL; Zimet GD
J Adolesc Health; 2011 Feb; 48(2):215-6. PubMed ID: 21257124
[No Abstract] [Full Text] [Related]
17. [Condyloma typing important for follow up of HPV vaccination. A condyloma reporting project].
Sturegård E; Johnsson A; Gustafsson E; Dillner J
Lakartidningen; 2008 Dec 10-16; 105(50):3648-50. PubMed ID: 19177930
[No Abstract] [Full Text] [Related]
18. New indication approved for HPV vaccine.
AIDS Patient Care STDS; 2011 Feb; 25(2):127. PubMed ID: 21370548
[No Abstract] [Full Text] [Related]
19. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
Harper DM
Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus vaccination: expected impacts and unresolved issues.
Dempsey AF; Freed GL
J Pediatr; 2008 Mar; 152(3):305-9. PubMed ID: 18280831
[No Abstract] [Full Text] [Related]
[Next] [New Search]
